Open AccessWITHDRAWN: Irinotecan plus Weekly 5-Fluorouracil and Leucovorin as Salvage Treatment for Patients with Metastatic Colorectal Cancer: A Phase II Trial
Author(s) -
John Souglakos,
N. Vardakis,
N. Androulakis,
Stylianos Kakolyris,
C. Kourousis,
Dimitris Mavroudis,
Athanasios Pallis,
Sofia Agelaki,
Kostas Kalbakis,
Vassilis Georgoulias
Publication year - 2007
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000099177
Subject(s) - medicine , irinotecan , neutropenia , regimen , fluorouracil , chemotherapy , oxaliplatin , colorectal cancer , gastroenterology , salvage therapy , surgery , progressive disease , phases of clinical research , performance status , febrile neutropenia , toxicity , folfiri , cancer
A phase II study was conducted to evaluate the toxicity and efficacy of irinotecan/5-fluorouracil/leucovorin (CPT-11/5-FU/LV (AIO schedule)) as salvage treatment in patients with metastatic colorectal cancer.